Skip to main content

Results for Compound Libraries ( 199 )

    • Ref: L1310
      Sizes: 1 mg, 100 μL, 30 μL, 250 μL, 50 μL
      From: £4,721.00

      A unique collection of 759 cytoskeleton-related compounds, can be used for HTS and HCS;

      Product detail
    • Ref: L1380
      Sizes: 1 mg, 100 μL, 30 μL, 250 μL, 50 μL
      From: £4,259.00

      Well-chosen 695 compounds with unique structures targeting transcription factor;

      Product detail
    • Ref: L1400
      Sizes: 1 mg, 100 μL, 30 μL, 250 μL, 50 μL
      From: £2,309.00

      A unique collection of 365 compounds targeting MAPK signaling for drug discovery in MAPK related diseases;

      Product detail
    • Ref: L1500
      Sizes: 1 mg, 100 μL, 30 μL, 250 μL, 50 μL
      From: £7,943.00

      A unique collection of 2223 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;

      Product detail
    • Ref: L1510
      Sizes: 1 mg, 100 μL, 30 μL, 250 μL, 50 μL
      From: £3,119.00

      A unique collection of 531 nuclear receptor signaling targeted compounds for high throughput and high content screening;

      Product detail
    • Ref: L1580
      Sizes: 1 mg, 100 μL, 30 μL, 250 μL, 50 μL
      From: £2,055.00

      Well-chosen 338 GPCR targeting compounds with unique structures;

      Product detail
    • Ref: L1600
      Sizes: 1 mg, 100 μL, 30 μL, 250 μL, 50 μL
      From: £13,180.00

      A unique collection of 2720 kinase inhibitors/regulators for high throughput screening and high content screening for drug discovery in kinase related diseases;

      Product detail
    • Ref: L1700
      Sizes: 1 mg, 100 μL, 30 μL, 250 μL, 50 μL
      From: £3,185.00

      A unique collection of 1040 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;

      Product detail
    • Ref: L1710
      Sizes: 100 μL, 30 μL, 250 μL, 50 μL
      From: £3,863.00

      A unique collection of 1133 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents;

      Product detail